BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4382281)

  • 1. Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties.
    Jaffe JJ; McCormack JJ
    Mol Pharmacol; 1967 Jul; 3(4):359-69. PubMed ID: 4382281
    [No Abstract]   [Full Text] [Related]  

  • 2. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 3. Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.
    Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1972 Jul; 32(7):1539-46. PubMed ID: 4402276
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence and properties of dihydrofolate reductases within the genus Trypanosoma.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Br J Pharmacol; 1968 Sep; 34(1):191P-192P. PubMed ID: 4300138
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 6. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
    Bertino JR; Cashmore AR; Hillcoat BL
    Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dihydrofolate reductase from baker's yeast. Purification and properties].
    Nagelschmidt M; Jaenicke L
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):773-81. PubMed ID: 4403556
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihydrofolate reductase from the L1210 R murine lymphoma. Further studies on the binding of substrates and inhibitors to the enzyme.
    Hillcoat BL; Perkins JP; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4777-81. PubMed ID: 4383525
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteriophage tail components. II. Dihydrofolate reductase in T4D bacteriophage.
    Kozloff LM; Verses C; Lute M; Crosby LK
    J Virol; 1970 Jun; 5(6):740-53. PubMed ID: 4393396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX.
    Smith CC; Freisheim JH
    Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296
    [No Abstract]   [Full Text] [Related]  

  • 11. Dihydrofolic reductase in human blood cells. I. Techniques for the study of enzyme activity and intracellular amethopterin content.
    Martelli MF; Tonato M; Grignani F
    Enzymol Biol Clin (Basel); 1967; 8(5):353-62. PubMed ID: 4383611
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence and properties of dihydrofolate reductases within the genus Crithidia.
    Gutteridge WE; McCormack JJ; Jaffe JJ
    Biochim Biophys Acta; 1969 May; 178(3):453-8. PubMed ID: 4389070
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydrofolate reductase. Purification and characterization of the enzyme from an amethopterin-resistant mutant of Escherichia coli.
    Poe M; Greenfield NJ; Hirshfield JM; Williams MN; Hoogsteen K
    Biochemistry; 1972 Mar; 11(6):1023-30. PubMed ID: 4401227
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
    Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
    Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 16. The essential SH-groups in folate reductase.
    Hakala MT
    Mol Pharmacol; 1968 Mar; 4(2):162-7. PubMed ID: 4384619
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes.
    Scott DA; Coombs GH; Sanderson BE
    Biochem Pharmacol; 1987 Jun; 36(12):2043-5. PubMed ID: 3593407
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.
    Ercikan E; Waltham M; Dicker A; Schweitzer B; Bertino JR
    Adv Exp Med Biol; 1993; 338():515-9. PubMed ID: 8304170
    [No Abstract]   [Full Text] [Related]  

  • 20. pH-Stat titration method for dihydrofolate reductase activity measurements: application to determination of substrate Michaelis constant and antifolate inhibition constant.
    Gilli R; Sari JC; Sica L; Bourdeaux M; Briand C
    Anal Biochem; 1986 Jan; 152(1):1-5. PubMed ID: 3954030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.